Utah Medical Products, Inc.
UTMD
$56.25
$0.7651.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.83M | 39.27M | 40.90M | 44.08M | 46.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.83M | 39.27M | 40.90M | 44.08M | 46.58M |
| Cost of Revenue | 16.57M | 16.36M | 16.76M | 18.16M | 19.10M |
| Gross Profit | 22.26M | 22.92M | 24.14M | 25.92M | 27.48M |
| SG&A Expenses | 7.71M | 7.65M | 7.60M | 8.01M | 9.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.86M | 24.71M | 25.17M | 27.01M | 28.99M |
| Operating Income | 13.97M | 14.56M | 15.73M | 17.07M | 17.59M |
| Income Before Tax | 15.49M | 15.86M | 16.80M | 18.21M | 18.81M |
| Income Tax Expenses | 2.93M | 2.90M | 2.93M | 2.95M | 3.18M |
| Earnings from Continuing Operations | 12.55 | 12.96 | 13.87 | 15.26 | 15.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.55M | 12.96M | 13.87M | 15.26M | 15.63M |
| EBIT | 13.97M | 14.56M | 15.73M | 17.07M | 17.59M |
| EBITDA | 16.86M | 17.40M | 18.53M | 20.17M | 21.74M |
| EPS Basic | 3.74 | 3.78 | 3.95 | 4.28 | 4.34 |
| Normalized Basic EPS | 3.13 | 3.20 | 3.37 | 3.62 | 3.67 |
| EPS Diluted | 3.73 | 3.77 | 3.95 | 4.27 | 4.33 |
| Normalized Diluted EPS | 3.13 | 3.20 | 3.37 | 3.62 | 3.67 |
| Average Basic Shares Outstanding | 13.42M | 13.71M | 14.02M | 14.26M | 14.41M |
| Average Diluted Shares Outstanding | 13.42M | 13.71M | 14.02M | 14.26M | 14.42M |
| Dividend Per Share | 1.22 | 1.21 | 1.21 | 1.20 | 1.20 |
| Payout Ratio | 32.72% | 32.32% | 30.70% | 28.14% | 27.59% |